Top Key Companies for Point-of-Care Coagulation Testing Market: Medtronic, Accriva Diagnostics, Micropoint Bioscience, Alere, Callegari Srl, F.Hoffmann-La Roche, CoaquSense, Abbott Laboratories, Goldsite Diagnostics Inc, Helena Point of Care, Diagon, TaiDoc Technology Corporation, Siemens Healthcare, Getein Biotech, Inc., ILine Microsystems, Sysmex, HemoSonics.
Global Point-of-Care Coagulation Testing Market Research Report: 2023-2030 Outlook with Market Insights, Industry and Competitive Analysis Included. Remarkable growth trajectory projected.
Global Point-of-Care Coagulation Testing Market Overview And Scope:
The Global Point-of-Care Coagulation Testing Market Report 2023 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Point-of-Care Coagulation Testing utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2023 and 2030. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Global Point-of-Care Coagulation Testing Market Segmentation
By Type, Point-of-Care Coagulation Testing market has been segmented into:
Prothrombin Time/International Normalized Tatio (PT-INR) Testing
Bleeding Time Testing
Fibrinogen Level Testing
Others
By Application, Point-of-Care Coagulation Testing market has been segmented into:
Retail Prices
Hospitals
Clinics
Health Centers
Homecare Settings
Regional Analysis of Point-of-Care Coagulation Testing Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Point-of-Care Coagulation Testing Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Point-of-Care Coagulation Testing market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Point-of-Care Coagulation Testing market.
Top Key Companies Covered in Point-of-Care Coagulation Testing market are:
Medtronic
Accriva Diagnostics
Micropoint Bioscience
Alere
Callegari Srl
F.Hoffmann-La Roche
CoaquSense
Abbott Laboratories
Goldsite Diagnostics Inc
Helena Point of Care
Diagon
TaiDoc Technology Corporation
Siemens Healthcare
Getein Biotech
Inc.
ILine Microsystems
Sysmex
HemoSonics
Key Questions answered in the Point-of-Care Coagulation Testing Market Report:
1. What is the expected Point-of-Care Coagulation Testing Market size during the forecast period, 2022-2028?
2. Which region is the largest market for the Point-of-Care Coagulation Testing Market?
3. What is the expected future scenario and the revenue generated by different regions and countries in the Point-of-Care Coagulation Testing Market, such as North America, Europe, AsiaPacific & Japan, China, U.K., South America, and Middle East and Africa?
4. What is the competitive strength of the key players in the Point-of-Care Coagulation Testing Market on the basis of the analysis of their recent developments, product offerings, and regional presence?
5. Where do the key Point-of-Care Coagulation Testing companies lie in their competitive benchmarking compared to the factors of market coverage and market potential?
6. How are the adoption scenario, related opportunities, and challenges impacting the Point-of-Care Coagulation Testing Markets?
7. How is the funding and investment landscape in the Point-of-Care Coagulation Testing Market?
8. Which are the leading consortiums and associations in the Point-of-Care Coagulation Testing Market, and what is their role in the market?
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Point-of-Care Coagulation Testing Market by Type
5.1 Point-of-Care Coagulation Testing Market Overview Snapshot and Growth Engine
5.2 Point-of-Care Coagulation Testing Market Overview
5.3 Prothrombin Time/International Normalized Tatio (PT-INR) Testing
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2030F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Prothrombin Time/International Normalized Tatio (PT-INR) Testing: Geographic Segmentation
5.4 Bleeding Time Testing
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2030F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Bleeding Time Testing: Geographic Segmentation
5.5 Fibrinogen Level Testing
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2030F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Fibrinogen Level Testing: Geographic Segmentation
5.6 Others
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2016-2030F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Others: Geographic Segmentation
Chapter 6: Point-of-Care Coagulation Testing Market by Application
6.1 Point-of-Care Coagulation Testing Market Overview Snapshot and Growth Engine
6.2 Point-of-Care Coagulation Testing Market Overview
6.3 Retail Prices
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2030F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Retail Prices: Geographic Segmentation
6.4 Hospitals
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2030F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Hospitals: Geographic Segmentation
6.5 Clinics
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2016-2030F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Clinics: Geographic Segmentation
6.6 Health Centers
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2016-2030F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Health Centers: Geographic Segmentation
6.7 Homecare Settings
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size (2016-2030F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 Homecare Settings: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Point-of-Care Coagulation Testing Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Point-of-Care Coagulation Testing Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Point-of-Care Coagulation Testing Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 MEDTRONIC
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 ACCRIVA DIAGNOSTICS
7.4 MICROPOINT BIOSCIENCE
7.5 ALERE
7.6 CALLEGARI SRL
7.7 F.HOFFMANN-LA ROCHE
7.8 COAQUSENSE
7.9 ABBOTT LABORATORIES
7.10 GOLDSITE DIAGNOSTICS INC
7.11 HELENA POINT OF CARE
7.12 DIAGON
7.13 TAIDOC TECHNOLOGY CORPORATION
7.14 SIEMENS HEALTHCARE
7.15 GETEIN BIOTECH
7.16 INC.
7.17 ILINE MICROSYSTEMS
7.18 SYSMEX
7.19 HEMOSONICS
Chapter 8: Global Point-of-Care Coagulation Testing Market Analysis, Insights and Forecast, 2016-2030
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Prothrombin Time/International Normalized Tatio (PT-INR) Testing
8.2.2 Bleeding Time Testing
8.2.3 Fibrinogen Level Testing
8.2.4 Others
8.3 Historic and Forecasted Market Size By Application
8.3.1 Retail Prices
8.3.2 Hospitals
8.3.3 Clinics
8.3.4 Health Centers
8.3.5 Homecare Settings
Chapter 9: North America Point-of-Care Coagulation Testing Market Analysis, Insights and Forecast, 2016-2030
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Prothrombin Time/International Normalized Tatio (PT-INR) Testing
9.4.2 Bleeding Time Testing
9.4.3 Fibrinogen Level Testing
9.4.4 Others
9.5 Historic and Forecasted Market Size By Application
9.5.1 Retail Prices
9.5.2 Hospitals
9.5.3 Clinics
9.5.4 Health Centers
9.5.5 Homecare Settings
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Point-of-Care Coagulation Testing Market Analysis, Insights and Forecast, 2016-2030
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Prothrombin Time/International Normalized Tatio (PT-INR) Testing
10.4.2 Bleeding Time Testing
10.4.3 Fibrinogen Level Testing
10.4.4 Others
10.5 Historic and Forecasted Market Size By Application
10.5.1 Retail Prices
10.5.2 Hospitals
10.5.3 Clinics
10.5.4 Health Centers
10.5.5 Homecare Settings
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Point-of-Care Coagulation Testing Market Analysis, Insights and Forecast, 2016-2030
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Prothrombin Time/International Normalized Tatio (PT-INR) Testing
11.4.2 Bleeding Time Testing
11.4.3 Fibrinogen Level Testing
11.4.4 Others
11.5 Historic and Forecasted Market Size By Application
11.5.1 Retail Prices
11.5.2 Hospitals
11.5.3 Clinics
11.5.4 Health Centers
11.5.5 Homecare Settings
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Point-of-Care Coagulation Testing Market Analysis, Insights and Forecast, 2016-2030
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Prothrombin Time/International Normalized Tatio (PT-INR) Testing
12.4.2 Bleeding Time Testing
12.4.3 Fibrinogen Level Testing
12.4.4 Others
12.5 Historic and Forecasted Market Size By Application
12.5.1 Retail Prices
12.5.2 Hospitals
12.5.3 Clinics
12.5.4 Health Centers
12.5.5 Homecare Settings
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Point-of-Care Coagulation Testing Market Analysis, Insights and Forecast, 2016-2030
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Prothrombin Time/International Normalized Tatio (PT-INR) Testing
13.4.2 Bleeding Time Testing
13.4.3 Fibrinogen Level Testing
13.4.4 Others
13.5 Historic and Forecasted Market Size By Application
13.5.1 Retail Prices
13.5.2 Hospitals
13.5.3 Clinics
13.5.4 Health Centers
13.5.5 Homecare Settings
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Point-of-Care Coagulation Testing Market Analysis, Insights and Forecast, 2016-2030
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Prothrombin Time/International Normalized Tatio (PT-INR) Testing
14.4.2 Bleeding Time Testing
14.4.3 Fibrinogen Level Testing
14.4.4 Others
14.5 Historic and Forecasted Market Size By Application
14.5.1 Retail Prices
14.5.2 Hospitals
14.5.3 Clinics
14.5.4 Health Centers
14.5.5 Homecare Settings
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Point-of-Care Coagulation Testing Scope:
Report Data
|
Point-of-Care Coagulation Testing Market
|
Point-of-Care Coagulation Testing Market Size in 2022
|
USD XXX million
|
Point-of-Care Coagulation Testing CAGR 2023 - 2030
|
XX%
|
Point-of-Care Coagulation Testing Base Year
|
2022
|
Point-of-Care Coagulation Testing Forecast Data
|
2023 - 2030
|
Segments Covered
|
By Type, By Application, And by Regions
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
Key Companies Profiled
|
Medtronic, Accriva Diagnostics, Micropoint Bioscience, Alere, Callegari Srl, F.Hoffmann-La Roche, CoaquSense, Abbott Laboratories, Goldsite Diagnostics Inc, Helena Point of Care, Diagon, TaiDoc Technology Corporation, Siemens Healthcare, Getein Biotech, Inc., ILine Microsystems, Sysmex, HemoSonics.
|
Key Segments
|
By Type
Prothrombin Time/International Normalized Tatio (PT-INR) Testing Bleeding Time Testing Fibrinogen Level Testing Others
By Applications
Retail Prices Hospitals Clinics Health Centers Homecare Settings
|